GB812366A
(en)
|
1955-08-18 |
1959-04-22 |
Wellcome Found |
Improvements in and relating to derivatives of pyrimidine and the preparation thereof
|
GB937725A
(en)
|
1960-05-11 |
1963-09-25 |
Ciba Ltd |
Pyrazolo[3:4-d]pyrimidines
|
DE2004713A1
(de)
|
1970-02-03 |
1971-08-12 |
Boehnnger Mannheim GmbH, 6800 Mann heim Waldhof |
Nitrofuryl triazolo pyrimidine und Verfahren zu ihrer Herstellung
|
US3657744A
(en)
|
1970-05-08 |
1972-04-25 |
Univ Minnesota |
Method for fixing prosthetic implants in a living body
|
IT1153216B
(it)
|
1981-10-16 |
1987-01-14 |
Schering Ag |
Procedimento per la preparazione di composti cianoeterociclici
|
DE3406533A1
(de)
|
1984-02-23 |
1985-08-29 |
Boehringer Mannheim Gmbh, 6800 Mannheim |
Verwendung von adenosin-derivaten als antiallergica und arzneimittel, die diese enthalten
|
US5310731A
(en)
|
1984-06-28 |
1994-05-10 |
Whitby Research, Inc. |
N-6 substituted-5'-(N-substitutedcarboxamido)adenosines as cardiac vasodilators and antihypertensive agents
|
JPS61109797A
(ja)
|
1984-11-01 |
1986-05-28 |
Yuki Gosei Yakuhin Kogyo Kk |
標識化ヌクレオチドおよび標識化ポリヌクレオチド
|
US4733665C2
(en)
|
1985-11-07 |
2002-01-29 |
Expandable Grafts Partnership |
Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft
|
US5023252A
(en)
|
1985-12-04 |
1991-06-11 |
Conrex Pharmaceutical Corporation |
Transdermal and trans-membrane delivery of drugs
|
US5061273A
(en)
|
1989-06-01 |
1991-10-29 |
Yock Paul G |
Angioplasty apparatus facilitating rapid exchanges
|
US5040548A
(en)
|
1989-06-01 |
1991-08-20 |
Yock Paul G |
Angioplasty mehtod
|
US5350395A
(en)
|
1986-04-15 |
1994-09-27 |
Yock Paul G |
Angioplasty apparatus facilitating rapid exchanges
|
US4748982A
(en)
|
1987-01-06 |
1988-06-07 |
Advanced Cardiovascular Systems, Inc. |
Reinforced balloon dilatation catheter with slitted exchange sleeve and method
|
US5001139A
(en)
|
1987-06-12 |
1991-03-19 |
American Cyanamid Company |
Enchancers for the transdermal flux of nivadipine
|
US4992445A
(en)
|
1987-06-12 |
1991-02-12 |
American Cyanamid Co. |
Transdermal delivery of pharmaceuticals
|
WO1990003370A1
(fr)
|
1988-09-28 |
1990-04-05 |
Microprobe Corporation |
DERIVES DE PYRAZOLO[3,4-d]PYRIMIDINE
|
CA1322628C
(fr)
|
1988-10-04 |
1993-10-05 |
Richard A. Schatz |
Greffon vasculaire intraluminal
|
GB8827305D0
(en)
|
1988-11-23 |
1988-12-29 |
British Bio Technology |
Compounds
|
US5428125A
(en)
|
1989-07-17 |
1995-06-27 |
The Dow Chemical Company |
Mesogenic polycyanates and thermosets thereof
|
US5442039A
(en)
|
1989-07-17 |
1995-08-15 |
The Dow Chemical Company |
Mesogenic polycyanates and thermosets thereof
|
US6344053B1
(en)
|
1993-12-22 |
2002-02-05 |
Medtronic Ave, Inc. |
Endovascular support device and method
|
US5292331A
(en)
|
1989-08-24 |
1994-03-08 |
Applied Vascular Engineering, Inc. |
Endovascular support device
|
US5674278A
(en)
|
1989-08-24 |
1997-10-07 |
Arterial Vascular Engineering, Inc. |
Endovascular support device
|
US5763597A
(en)
|
1989-09-15 |
1998-06-09 |
Metabasis Therapeutics, Inc. |
Orally active adenosine kinase inhibitors
|
US5763596A
(en)
|
1989-09-15 |
1998-06-09 |
Metabasis Therapeutics, Inc. |
C-4' modified adenosine kinase inhibitors
|
US5646128A
(en)
|
1989-09-15 |
1997-07-08 |
Gensia, Inc. |
Methods for treating adenosine kinase related conditions
|
US5721356A
(en)
|
1989-09-15 |
1998-02-24 |
Gensia, Inc. |
Orally active adenosine kinase inhibitors
|
US5795977A
(en)
|
1989-09-15 |
1998-08-18 |
Metabasis Therapeutics, Inc. |
Water soluble adenosine kinase inhibitors
|
US5674998A
(en)
|
1989-09-15 |
1997-10-07 |
Gensia Inc. |
C-4' modified adenosine kinase inhibitors
|
GB9009542D0
(en)
|
1990-04-27 |
1990-06-20 |
Beecham Group Plc |
Novel compounds
|
GB9113137D0
(en)
|
1990-07-13 |
1991-08-07 |
Ici Plc |
Thioxo heterocycles
|
DE4026265A1
(de)
|
1990-08-20 |
1992-02-27 |
Boehringer Mannheim Gmbh |
Neue phospholipid-derivate von nucleosiden, deren herstellung sowie deren verwendung als antivirale arzneimittel
|
US5563257A
(en)
|
1990-08-20 |
1996-10-08 |
Boehringer Mannheim Gmbh |
Phospholipid derivatives of nucleosides
|
US5652366A
(en)
|
1990-09-25 |
1997-07-29 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
DI (1R)-(-)camphosulfonic acid) salt, preparation thereof and use thereof
|
ATE147074T1
(de)
|
1990-09-25 |
1997-01-15 |
Rhone Poulenc Rorer Int |
Verbindungen welche antihypertensive und antiischemische eigenschaften besitzen
|
US5561134A
(en)
|
1990-09-25 |
1996-10-01 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
|
GB9103839D0
(en)
|
1991-02-23 |
1991-04-10 |
Smithkline Beecham Plc |
Pharmaceuticals
|
US5916891A
(en)
|
1992-01-13 |
1999-06-29 |
Smithkline Beecham Corporation |
Pyrimidinyl imidazoles
|
IL104369A0
(en)
|
1992-01-13 |
1993-05-13 |
Smithkline Beecham Corp |
Novel compounds and compositions
|
DE4204031A1
(de)
|
1992-02-12 |
1993-08-19 |
Boehringer Mannheim Gmbh |
Neue lipidphosphonsaeure-nucleosid-konjugate sowie deren verwendung als antivirale arzneimittel
|
DE4204032A1
(de)
|
1992-02-12 |
1993-08-19 |
Boehringer Mannheim Gmbh |
Neue liponucleotide, deren herstellunmg sowie deren verwendung als antivirale arzneimittel
|
WO1993018035A1
(fr)
|
1992-03-04 |
1993-09-16 |
Abbott Laboratories |
Antagonistes des recepteurs de l'angiotensine ii
|
GB9208135D0
(en)
|
1992-04-13 |
1992-05-27 |
Ludwig Inst Cancer Res |
Polypeptides having kinase activity,their preparation and use
|
AU4115693A
(en)
|
1992-04-24 |
1993-11-29 |
Sri International |
In vivo homologous sequence targeting in eukaryotic cells
|
CA2117476C
(fr)
*
|
1992-06-19 |
2000-02-22 |
R. Andrew Wood |
Camera a infrarouge a stabilisation thermoelectrique de la temperature
|
US6057305A
(en)
*
|
1992-08-05 |
2000-05-02 |
Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic |
Antiretroviral enantiomeric nucleotide analogs
|
TW444018B
(en)
|
1992-12-17 |
2001-07-01 |
Pfizer |
Pyrazolopyrimidines
|
US5455258A
(en)
|
1993-01-06 |
1995-10-03 |
Ciba-Geigy Corporation |
Arylsulfonamido-substituted hydroxamic acids
|
EP0684953A4
(fr)
|
1993-02-03 |
1999-12-22 |
Gensia Inc |
Inhibiteurs d'adenosine-kinase comprenant des derives de lyxofuranosyle.
|
IL108523A0
(en)
|
1993-02-03 |
1994-05-30 |
Gensia Inc |
Pharmaceutical compositions containing adenosine kinase inhibitors for preventing or treating conditions involving inflammatory responses and pain
|
AU6672794A
(en)
|
1993-11-05 |
1995-05-23 |
Biochem Pharma Inc. |
Antineoplastic heteronaphthoquinones
|
US5654307A
(en)
|
1994-01-25 |
1997-08-05 |
Warner-Lambert Company |
Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
|
IL112249A
(en)
|
1994-01-25 |
2001-11-25 |
Warner Lambert Co |
Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds
|
US6632789B1
(en)
|
1994-04-29 |
2003-10-14 |
The United States Of America As Represented By The Secretary Of The Navy |
Methods for modulating T cell responses by manipulating intracellular signal transduction
|
DE4418690A1
(de)
|
1994-05-28 |
1996-01-11 |
Boehringer Mannheim Gmbh |
Neue Lipidester von Nucleosid-Monophosphaten und deren Verwendung als immunsuppressive Arzneimittel
|
US6323201B1
(en)
|
1994-12-29 |
2001-11-27 |
The Regents Of The University Of California |
Compounds for inhibition of ceramide-mediated signal transduction
|
US5863949A
(en)
|
1995-03-08 |
1999-01-26 |
Pfizer Inc |
Arylsulfonylamino hydroxamic acid derivatives
|
US6312894B1
(en)
|
1995-04-03 |
2001-11-06 |
Epoch Pharmaceuticals, Inc. |
Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders
|
WO1996031510A1
(fr)
|
1995-04-03 |
1996-10-10 |
Novartis Ag |
Derives de pyrazole et leurs procedes de preparation
|
CA2218503C
(fr)
|
1995-04-20 |
2001-07-24 |
Pfizer Inc. |
Derives d'acide hydroxamique arylsufonyle en tant qu'inhibiteurs de mmp et de tnf
|
US5977061A
(en)
|
1995-04-21 |
1999-11-02 |
Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic |
N6 - substituted nucleotide analagues and their use
|
US5593997A
(en)
|
1995-05-23 |
1997-01-14 |
Pfizer Inc. |
4-aminopyrazolo(3-,4-D)pyrimidine and 4-aminopyrazolo-(3,4-D)pyridine tyrosine kinase inhibitors
|
US6403599B1
(en)
|
1995-11-08 |
2002-06-11 |
Pfizer Inc |
Corticotropin releasing factor antagonists
|
IL122246A
(en)
|
1995-06-07 |
2004-06-01 |
Searle & Co |
Combination of spironolactone and angiotensin II antagonist for the treatment of heart failure
|
DK0831910T3
(da)
|
1995-06-07 |
2002-05-21 |
Searle & Co |
Kombinationsterapi med epoxy-steroid aldosteronantagonist og angiotensin II-receptorantagonist til behandling af kongestivt hjertesvigt
|
US5665721A
(en)
|
1995-06-07 |
1997-09-09 |
Abbott Laboratories |
Heterocyclic substituted cyclopentane compounds
|
AU5982296A
(en)
|
1995-06-07 |
1996-12-30 |
G.D. Searle & Co. |
Method to treat cardiofibrosis with a combination of an angi otensin ii antagonist and spironolactone
|
US5763885A
(en)
|
1995-12-19 |
1998-06-09 |
Loral Infrared & Imaging Systems, Inc. |
Method and apparatus for thermal gradient stabilization of microbolometer focal plane arrays
|
GB9521987D0
(en)
|
1995-10-26 |
1996-01-03 |
Ludwig Inst Cancer Res |
Phosphoinositide 3-kinase modulators
|
PT780386E
(pt)
|
1995-12-20 |
2003-02-28 |
Hoffmann La Roche |
Inibidores de metaloprotease de matriz
|
US5747235A
(en)
|
1996-01-26 |
1998-05-05 |
Eastman Kodak Company |
Silver halide light sensitive emulsion layer having enhanced photographic sensitivity
|
CH690773A5
(de)
|
1996-02-01 |
2001-01-15 |
Novartis Ag |
Pyrrolo(2,3-d)pyrimide und ihre Verwendung.
|
DE19603576A1
(de)
|
1996-02-01 |
1997-08-07 |
Bayer Ag |
Acylierte 4-Amino und 4-Hydrazinopyrimidine
|
GB2310952B
(en)
|
1996-03-05 |
1998-08-19 |
Mitsubishi Electric Corp |
Infrared detector
|
GB9611460D0
(en)
*
|
1996-06-01 |
1996-08-07 |
Ludwig Inst Cancer Res |
Novel lipid kinase
|
AU727708B2
(en)
|
1996-06-20 |
2000-12-21 |
Board Of Regents, The University Of Texas System |
Compounds and methods for providing pharmacologically active preparations and uses thereof
|
NZ333303A
(en)
|
1996-07-18 |
2000-06-23 |
Lawrence Alan Reiter |
Phosphinate based inhibitors of matrix metalloproteases
|
BR9711223A
(pt)
|
1996-08-23 |
1999-08-17 |
Pfizer |
Derivados de cido arilsulfonilamino-hidrox mico
|
DE69732780T2
(de)
|
1996-10-02 |
2006-04-06 |
Novartis Ag |
Pyrimiderivate und verfahren zu ihrer herstellung
|
US6153631A
(en)
|
1996-10-23 |
2000-11-28 |
Zymogenetics, Inc. |
Compositions and methods for treating bone deficit conditions
|
US5990169A
(en)
|
1996-10-23 |
1999-11-23 |
Zymogenetics, Inc. |
Compositions and methods for treating bone deficit conditions
|
US5919808A
(en)
|
1996-10-23 |
1999-07-06 |
Zymogenetics, Inc. |
Compositions and methods for treating bone deficit conditions
|
US5922753A
(en)
|
1996-10-23 |
1999-07-13 |
Zymogenetics, Inc. |
Methods for treating bone deficit conditions with benzothiazole
|
US6251901B1
(en)
|
1996-10-23 |
2001-06-26 |
Zymogenetics, Inc. |
Compositions and methods for treating bone deficit conditions
|
US5965573A
(en)
|
1996-10-23 |
1999-10-12 |
Zymogenetics, Inc. |
Compositions and methods for treating bone deficit conditions
|
US5994358A
(en)
|
1996-10-23 |
1999-11-30 |
Zymogenetics, Inc. |
Compositions and methods for treating bone deficit conditions
|
US5948776A
(en)
|
1996-10-23 |
1999-09-07 |
Zymogenetic, Inc. |
Compositions and methods for treating bone deficit conditions
|
US6342514B1
(en)
|
1996-10-23 |
2002-01-29 |
Zymogenetics, Inc. |
Compositions and methods for treating bone deficit conditions
|
US5858753A
(en)
|
1996-11-25 |
1999-01-12 |
Icos Corporation |
Lipid kinase
|
JP4094066B2
(ja)
*
|
1996-12-06 |
2008-06-04 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
インターロイキン−1β変換酵素のインヒビター
|
US6093737A
(en)
|
1996-12-30 |
2000-07-25 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
EP0950059B1
(fr)
|
1997-01-06 |
2004-08-04 |
Pfizer Inc. |
Derives de sulfone cyclique
|
IL131042A
(en)
|
1997-02-03 |
2004-07-25 |
Pfizer Prod Inc |
Derivatives of arylsulfonamic acid hydroxyamic acid and medicinal preparations containing them
|
EP1017823B1
(fr)
*
|
1997-02-07 |
2004-07-14 |
Princeton University |
Proteines kinases manipulees capables d'utiliser des substrats a triphosphate nucleotidique modifies
|
EP0966438A1
(fr)
|
1997-02-07 |
1999-12-29 |
Pfizer Inc. |
Derives du n-hxdroxy-beta-sulfonyl-propionamide et leur utilisation comme inhibiteurs des metalloproteases matrices
|
HUP0000657A3
(en)
|
1997-02-11 |
2000-10-30 |
Pfizer |
N-arylsulfonyl-piperidine, -morpholine hydroxamic acid derivatives and pharmaceutical compositions containing them
|
HUP0001507A3
(en)
|
1997-03-19 |
2002-01-28 |
Abbott Gmbh & Co Kg |
Pyrrolo [2,3-d] pyrimidine derivatives, process for their preparation, their use and pharmaceutical compositions containing them
|
US7863444B2
(en)
|
1997-03-19 |
2011-01-04 |
Abbott Laboratories |
4-aminopyrrolopyrimidines as kinase inhibitors
|
WO1998043962A1
(fr)
*
|
1997-03-28 |
1998-10-08 |
Du Pont Pharmaceuticals Company |
Promedicaments heterocycliques inhibiteurs d'integrine
|
EP0983768A1
(fr)
|
1997-05-23 |
2000-03-08 |
Nippon Shinyaku Co., Ltd. |
Preparation medicamenteuse aux fins de la prevention et du traitement des hepatopathies
|
GB9711650D0
(en)
|
1997-06-05 |
1997-07-30 |
Pfizer Ltd |
Compounds useful in therapy
|
US6207679B1
(en)
|
1997-06-19 |
2001-03-27 |
Sepracor, Inc. |
Antimicrobial agents uses and compositions related thereto
|
EP1020445B1
(fr)
|
1997-10-02 |
2008-08-13 |
Eisai R&D Management Co., Ltd. |
Derives de pyridine condenses
|
US6649631B1
(en)
|
1997-10-23 |
2003-11-18 |
The Board Of Regents Of The University Of Texas System |
Compositions and methods for treating bone deficit conditions
|
KR100540046B1
(ko)
|
1997-11-12 |
2006-01-10 |
미쓰비시 가가꾸 가부시키가이샤 |
퓨린유도체 및 이를 유효성분으로 함유하는 의약
|
GB9725782D0
(en)
|
1997-12-05 |
1998-02-04 |
Pfizer Ltd |
Therapeutic agents
|
US6191170B1
(en)
|
1998-01-13 |
2001-02-20 |
Tularik Inc. |
Benzenesulfonamides and benzamides as therapeutic agents
|
GB9801690D0
(en)
|
1998-01-27 |
1998-03-25 |
Pfizer Ltd |
Therapeutic agents
|
US6127121A
(en)
|
1998-04-03 |
2000-10-03 |
Epoch Pharmaceuticals, Inc. |
Oligonucleotides containing pyrazolo[3,4-D]pyrimidines for hybridization and mismatch discrimination
|
US7715989B2
(en)
|
1998-04-03 |
2010-05-11 |
Elitech Holding B.V. |
Systems and methods for predicting oligonucleotide melting temperature (TmS)
|
PA8469401A1
(es)
|
1998-04-10 |
2000-05-24 |
Pfizer Prod Inc |
Derivados biciclicos del acido hidroxamico
|
PA8469501A1
(es)
|
1998-04-10 |
2000-09-29 |
Pfizer Prod Inc |
Hidroxamidas del acido (4-arilsulfonilamino)-tetrahidropiran-4-carboxilico
|
US6251689B1
(en)
|
1998-05-14 |
2001-06-26 |
Telik, Inc. |
Methods for the solid phase synthesis of combinatorial libraries of benzimidazoles benzoxazoles benzothiazoles and derivatives thereof
|
AR020590A1
(es)
|
1998-06-02 |
2002-05-22 |
Cadus Pharmaceutical Corp |
7-diazapurina-n-6 sustituida, un metodo para su preparacion, composiciones farmaceuticas que la comprenden
|
JP2000072773A
(ja)
|
1998-08-28 |
2000-03-07 |
Zeria Pharmaceut Co Ltd |
プリン誘導体
|
US6713474B2
(en)
|
1998-09-18 |
2004-03-30 |
Abbott Gmbh & Co. Kg |
Pyrrolopyrimidines as therapeutic agents
|
KR20010085822A
(ko)
|
1998-09-18 |
2001-09-07 |
스타르크, 카르크 |
키나제 억제제로서의 4-아미노피롤로피리미딘
|
ATE248834T1
(de)
|
1998-11-16 |
2003-09-15 |
Basf Ag |
Herbizide 3-(benzo(ox/thi)azol-7-yl)-1h-pyrimidin-2,4-dio e
|
US6319660B1
(en)
|
1998-12-28 |
2001-11-20 |
Eastman Kodak Company |
Color photographic element containing speed improving compound
|
ES2206191T3
(es)
|
1999-01-11 |
2004-05-16 |
Princeton University |
Inhibidores de alta afinidad para validacion de dianas y usos de los mismos.
|
CZ27399A3
(cs)
*
|
1999-01-26 |
2000-08-16 |
Ústav Experimentální Botaniky Av Čr |
Substituované dusíkaté heterocyklické deriváty, způsob jejich přípravy, tyto deriváty pro použití jako léčiva, farmaceutická kompozice a kombinovaný farmaceutický přípravek tyto deriváty obsahující a použití těchto derivátů pro výrobu léčiv
|
EP1040831A3
(fr)
*
|
1999-04-02 |
2003-05-02 |
Pfizer Products Inc. |
Utilisation d'antagonistes du facteur de libération de la corticotropine pour la prévention de la mort subite
|
SE515856C2
(sv)
|
1999-05-19 |
2001-10-22 |
Ericsson Telefon Ab L M |
Bärare för elektronikkomponenter
|
EP1181282A2
(fr)
|
1999-06-03 |
2002-02-27 |
Basf Aktiengesellschaft |
Composes de benzothiazinone et de benzoxazinone
|
US6387894B1
(en)
|
1999-06-11 |
2002-05-14 |
Pfizer Inc. |
Use of CRF antagonists and renin-angiotensin system inhibitors
|
PE20010306A1
(es)
|
1999-07-02 |
2001-03-29 |
Agouron Pharma |
Compuestos de indazol y composiciones farmaceuticas que los contienen utiles para la inhibicion de proteina kinasa
|
TWI262914B
(en)
*
|
1999-07-02 |
2006-10-01 |
Agouron Pharma |
Compounds and pharmaceutical compositions for inhibiting protein kinases
|
GB9919588D0
(en)
|
1999-08-18 |
1999-10-20 |
Hoechst Schering Agrevo Gmbh |
Fungicidal compounds
|
EP1216232B1
(fr)
|
1999-08-27 |
2006-10-11 |
ChemoCentryx Inc |
Composes et techniques permettant de moduler la fonction du recepteur cxcr3
|
EP1516876A1
(fr)
*
|
1999-09-16 |
2005-03-23 |
Curis, Inc. |
Mediateurs des voies de signalisations "hedgehog" ,compositions et utilisations associées.
|
US6921763B2
(en)
|
1999-09-17 |
2005-07-26 |
Abbott Laboratories |
Pyrazolopyrimidines as therapeutic agents
|
SK3812002A3
(en)
|
1999-09-17 |
2003-09-11 |
Abbott Gmbh & Co Kg |
Pyrazolopyrimidines as therapeutic agents
|
US6506769B2
(en)
|
1999-10-06 |
2003-01-14 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Heterocyclic compounds useful as inhibitors of tyrosine kinases
|
MXPA02003364A
(es)
|
1999-10-06 |
2002-08-23 |
Boehringer Ingelheim Pharma |
Compuestos heterociclicos utiles como inhibidores de las cinasas de tirosina.
|
US6472153B1
(en)
|
1999-10-26 |
2002-10-29 |
Epoch Biosciences, Inc. |
Hybridization-triggered fluorescent detection of nucleic acids
|
US6660845B1
(en)
|
1999-11-23 |
2003-12-09 |
Epoch Biosciences, Inc. |
Non-aggregating, non-quenching oligomers comprising nucleotide analogues; methods of synthesis and use thereof
|
GB0002032D0
(en)
|
2000-01-28 |
2000-03-22 |
Zeneca Ltd |
Chemical compounds
|
US7217722B2
(en)
|
2000-02-01 |
2007-05-15 |
Kirin Beer Kabushiki Kaisha |
Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same
|
US7115653B2
(en)
|
2000-03-30 |
2006-10-03 |
Curis, Inc. |
Small organic molecule regulators of cell proliferation
|
US6613798B1
(en)
|
2000-03-30 |
2003-09-02 |
Curis, Inc. |
Small organic molecule regulators of cell proliferation
|
EP1278748B1
(fr)
|
2000-04-25 |
2011-03-23 |
ICOS Corporation |
Inhibiteurs de la phosphatidyl-inositol 3-kinase delta humaine
|
US6667300B2
(en)
|
2000-04-25 |
2003-12-23 |
Icos Corporation |
Inhibitors of human phosphatidylinositol 3-kinase delta
|
AU2001265137B2
(en)
|
2000-05-30 |
2007-06-14 |
Indiana University Research And Technology Corporation |
Compositions and methods for identifying agents which modulate PTEN function and PI-3 kinase pathways
|
JP2004501915A
(ja)
*
|
2000-06-27 |
2004-01-22 |
ジェネラブス・テクノロジーズ・インコーポレーテッド |
抗菌、抗真菌または抗腫瘍活性を有する新規な化合物
|
US6534691B2
(en)
|
2000-07-18 |
2003-03-18 |
E. I. Du Pont De Nemours And Company |
Manufacturing process for α-olefins
|
DE60138714D1
(de)
|
2000-10-11 |
2009-06-25 |
Applera Corp |
Fluoreszierende nukleobasekonjugate mit anionische linker
|
AU2002213467A1
(en)
|
2000-10-11 |
2002-04-22 |
Chemocentryx, Inc. |
Modulation of ccr4 function
|
JP2002131859A
(ja)
|
2000-10-19 |
2002-05-09 |
Konica Corp |
撮影用赤外感光性ハロゲン化銀写真感光材料及び赤外感光性ハロゲン化銀乳剤
|
US6890747B2
(en)
*
|
2000-10-23 |
2005-05-10 |
Warner-Lambert Company |
Phosphoinositide 3-kinases
|
CZ20031910A3
(cs)
|
2000-12-11 |
2003-12-17 |
Tularik Inc. |
Sloučenina s antagonistickými účinky na CXCR3 a farmaceutický postředek
|
TWI312779B
(fr)
|
2000-12-28 |
2009-08-01 |
Daiichi Seiyaku Co |
|
EP2399588B1
(fr)
|
2001-01-22 |
2020-04-29 |
Merck Sharp & Dohme Corp. |
Dérivés de nucléosides en tant qu'inhibiteurs de polymérase virale d'arn dépendante de l'arn
|
US7105499B2
(en)
|
2001-01-22 |
2006-09-12 |
Merck & Co., Inc. |
Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
|
MXPA03008560A
(es)
|
2001-03-22 |
2004-06-30 |
Abbot Gmbh & Co Kg |
Pirazolopirimidinas como agentes terapeuticos.
|
WO2002088025A1
(fr)
|
2001-04-26 |
2002-11-07 |
New York University |
Procede de dissolution de nanotubes en carbone
|
JP2004528376A
(ja)
|
2001-05-08 |
2004-09-16 |
クドス ファーマシューティカルズ リミテッド |
Parp阻害薬としてのイソキノリノン誘導体
|
WO2002094264A1
(fr)
|
2001-05-23 |
2002-11-28 |
Tularik Inc. |
Antagonistes de ccr4
|
WO2002101007A2
(fr)
*
|
2001-06-13 |
2002-12-19 |
Genesoft Pharmaceuticals, Inc |
Composes benzamides anti-pathogenes
|
EP1401817A4
(fr)
|
2001-06-13 |
2005-11-02 |
Genesoft Pharmaceuticals Inc |
Composes isoquinoline presentant une activite anti-infectieuse
|
CA2450628A1
(fr)
|
2001-06-13 |
2002-12-19 |
Genesoft Pharmaceuticals, Inc. |
Composes benzothiophene presentant une activite anti-infectieuse
|
GB0115109D0
(en)
|
2001-06-21 |
2001-08-15 |
Aventis Pharma Ltd |
Chemical compounds
|
US20030114467A1
(en)
|
2001-06-21 |
2003-06-19 |
Shakespeare William C. |
Novel pyrazolo- and pyrrolo-pyrimidines and uses thereof
|
DE60216115T2
(de)
|
2001-08-01 |
2007-05-31 |
Merck & Co., Inc. |
BENZIMIDAZO 4,5-föISOCHINOLINON-DERIVATE
|
WO2003020880A2
(fr)
|
2001-08-03 |
2003-03-13 |
Abbott Laboratories |
Procedes relatifs a l'identification d'inhibiteurs de kinase de cellule lymphocytaire (lck)
|
ATE550320T1
(de)
|
2001-08-10 |
2012-04-15 |
Shionogi & Co |
Antivirales mittel
|
JP2003073357A
(ja)
|
2001-09-03 |
2003-03-12 |
Mitsubishi Pharma Corp |
アミド化合物を含有するRhoキナーゼ阻害剤
|
WO2003024969A1
(fr)
|
2001-09-14 |
2003-03-27 |
Merck & Co., Inc. |
Inhibiteurs des tyrosine kinases
|
AU2002368274A1
(en)
|
2001-09-13 |
2004-06-03 |
Genesoft, Inc. |
Methods of treating infection by drug resistant bacteria
|
AUPR769501A0
(en)
|
2001-09-14 |
2001-10-11 |
Biomolecular Research Institute Limited |
Cytokine receptor 1
|
TWI330183B
(fr)
*
|
2001-10-22 |
2010-09-11 |
Eisai R&D Man Co Ltd |
|
JP4397691B2
(ja)
|
2001-10-30 |
2010-01-13 |
コンフォーマ・セラピューティクス・コーポレイション |
Hsp90阻害活性を有するプリン類似体
|
US7319858B2
(en)
|
2001-11-16 |
2008-01-15 |
Cingular Wireless Ii, Llc |
System and method for querying message information
|
AU2002350217A1
(en)
|
2001-12-04 |
2003-06-17 |
Bristol-Myers Squibb Company |
Glycinamides as factor xa inhibitors
|
AU2002351412B2
(en)
|
2001-12-21 |
2010-05-20 |
Exelixis Patent Company Llc |
Modulators of LXR
|
JP4085237B2
(ja)
|
2001-12-21 |
2008-05-14 |
日本電気株式会社 |
携帯電話の利用契約システムと通信方法
|
AU2002364209A1
(en)
|
2001-12-26 |
2003-07-24 |
Genelabs Technologies, Inc. |
Polyamide derivatives possessing antibacterial, antifungal or antitumor activity
|
US7414036B2
(en)
|
2002-01-25 |
2008-08-19 |
Muscagen Limited |
Compounds useful as A3 adenosine receptor agonists
|
US20030225098A1
(en)
|
2002-03-21 |
2003-12-04 |
Hirst Gavin C. |
Kinase inhibitors
|
AU2003225933A1
(en)
|
2002-03-22 |
2003-10-13 |
Cellular Genomics, Inc. |
AN IMPROVED FORMULATION OF CERTAIN PYRAZOLO(3,4-d) PYRIMIDINES AS KINASE MODULATORS
|
EP1503988B1
(fr)
|
2002-03-26 |
2009-07-22 |
Biofrontera Discovery Gmbh |
Derives de fredericamycine
|
US7166293B2
(en)
|
2002-03-29 |
2007-01-23 |
Carlsbad Technology, Inc. |
Angiogenesis inhibitors
|
DE10217046A1
(de)
|
2002-04-17 |
2003-11-06 |
Bioleads Gmbh |
Fredericamycin-Derivate
|
CA2483500A1
(fr)
|
2002-04-26 |
2003-11-06 |
Pfizer Products Inc. |
Inhibiteurs de metalloproteinase a base de pyrimidine-2, 4, 6-trione
|
EP1517904A4
(fr)
|
2002-05-23 |
2007-02-21 |
Merck & Co Inc |
Inhibiteurs de kinesine mitotique
|
EP1556357A4
(fr)
|
2002-06-14 |
2006-09-13 |
Cytokinetics Inc |
Composes, compositions et procedes
|
RU2340605C2
(ru)
|
2002-06-27 |
2008-12-10 |
Ново Нордиск А/С |
Арилкарбонильные производные в качестве терапевтических средств
|
MXPA05000130A
(es)
|
2002-06-27 |
2005-02-17 |
Novo Nordisk As |
Derivados de aril-carbonilo como agentes terapeuticos.
|
US7265111B2
(en)
|
2002-06-27 |
2007-09-04 |
Sanofi-Aventis Deutschland Gmbh |
Adenosine analogues and their use as pharmaceutical agents
|
DE10230917A1
(de)
|
2002-07-09 |
2004-02-05 |
Bioleads Gmbh |
Fredericamycin-Derivate
|
AU2003249244A1
(en)
|
2002-07-15 |
2004-02-02 |
Combinatorx, Incorporated |
Methods for the treatment of neoplasms
|
AU2003249532A1
(en)
|
2002-08-13 |
2004-02-25 |
Warner-Lambert Company Llc |
4-hydroxyquinoline derivatives as matrix metalloproteinase inhibitors
|
JP4646626B2
(ja)
|
2002-08-16 |
2011-03-09 |
アストラゼネカ アクチボラグ |
ホスホイノシチド3−キナーゼβの阻害
|
US20040048853A1
(en)
|
2002-08-21 |
2004-03-11 |
Gustave Bergnes |
Compounds, compositions, and methods
|
US20030139427A1
(en)
|
2002-08-23 |
2003-07-24 |
Osi Pharmaceuticals Inc. |
Bicyclic pyrimidinyl derivatives and methods of use thereof
|
AU2003266668A1
(en)
|
2002-09-30 |
2004-04-23 |
Banyu Pharmaceutical Co., Ltd. |
2-aminobenzimidazole derivative
|
JP2004161716A
(ja)
|
2002-11-15 |
2004-06-10 |
Takeda Chem Ind Ltd |
Jnk阻害剤
|
UA80171C2
(en)
|
2002-12-19 |
2007-08-27 |
Pfizer Prod Inc |
Pyrrolopyrimidine derivatives
|
WO2004058717A1
(fr)
|
2002-12-20 |
2004-07-15 |
X-Ceptor Therapeutics, Inc. |
Derives d'isoquinolinone et leur utilisation comme agents therapeutiques
|
WO2004056746A1
(fr)
|
2002-12-23 |
2004-07-08 |
4Sc Ag |
Composes d'acide dicarboxylique de cycloalcene servant d'agents anti-inflammatoires, d'immunomodulation et anti-proliferation
|
US7365094B2
(en)
*
|
2002-12-23 |
2008-04-29 |
4Sc Ag |
Compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
|
US7247736B2
(en)
|
2002-12-23 |
2007-07-24 |
4Sc Ag |
Method of identifying inhibitors of DHODH
|
CN1756735A
(zh)
|
2003-03-06 |
2006-04-05 |
帝斯曼知识产权资产管理有限公司 |
α-氨羰基化合物的制备方法
|
WO2004087053A2
(fr)
|
2003-03-25 |
2004-10-14 |
Syrrx, Inc. |
Inhibiteurs de dipeptidyle peptidase
|
GB0306907D0
(en)
|
2003-03-26 |
2003-04-30 |
Angiogene Pharm Ltd |
Boireductively-activated prodrugs
|
WO2004103270A2
(fr)
|
2003-04-02 |
2004-12-02 |
Suntory Pharmaceutical Research Laboratories Llc |
Composes et procedes destines au traitement de la thrombose
|
EP1646615B1
(fr)
|
2003-06-06 |
2009-08-26 |
Vertex Pharmaceuticals Incorporated |
Derives de pyrimidne utilises en tant que modulateurs de transporteurs de cassette de liaison a l'atp
|
US7429596B2
(en)
|
2003-06-20 |
2008-09-30 |
The Regents Of The University Of California |
1H-pyrrolo [2,3-D] pyrimidine derivatives and methods of use thereof
|
WO2005002585A1
(fr)
|
2003-07-02 |
2005-01-13 |
Warner-Lambert Company Llc |
Combinaison d'un inhibiteur allosterique de la metalloproteinase-13 matricielle et d'un ligand au recepteur alpha-2-delta
|
BRPI0413005A
(pt)
|
2003-07-29 |
2006-09-26 |
Irm Llc |
compostos e composições como inibidores da proteìna cinase
|
GB0317951D0
(en)
|
2003-07-31 |
2003-09-03 |
Trigen Ltd |
Compounds
|
US7459472B2
(en)
|
2003-08-08 |
2008-12-02 |
Transtech Pharma, Inc. |
Aryl and heteroaryl compounds, compositions, and methods of use
|
US7208601B2
(en)
|
2003-08-08 |
2007-04-24 |
Mjalli Adnan M M |
Aryl and heteroaryl compounds, compositions, and methods of use
|
WO2005016348A1
(fr)
*
|
2003-08-14 |
2005-02-24 |
Icos Corporation |
Methodes d'inhibition de reponses immunes stimulees par un facteur endogene
|
WO2005016349A1
(fr)
|
2003-08-14 |
2005-02-24 |
Icos Corporation |
Methodes d'inhibition de l'accumulation des leucocytes
|
AU2004264419B2
(en)
|
2003-08-15 |
2009-01-15 |
Irm Llc |
6-substituted anilino purines as RTK inhibitors
|
US7390820B2
(en)
|
2003-08-25 |
2008-06-24 |
Amgen Inc. |
Substituted quinolinone derivatives and methods of use
|
WO2005044181A2
(fr)
|
2003-09-09 |
2005-05-19 |
Temple University-Of The Commonwealth System Of Higher Education |
Protection de tissus et de cellules des effets cytotoxiques d'un rayonnement ionisant par des inhibiteurs abl
|
CN101906106A
(zh)
|
2003-09-18 |
2010-12-08 |
康福玛医药公司 |
作为hsp90-抑制剂的新的杂环化合物
|
GB0322409D0
(en)
|
2003-09-25 |
2003-10-29 |
Astrazeneca Ab |
Quinazoline derivatives
|
EP1673343A4
(fr)
|
2003-10-08 |
2008-09-10 |
Irm Llc |
Composes et compositions convenant comme inhibiteurs de proteine-kinases
|
AU2004289303A1
(en)
|
2003-11-10 |
2005-05-26 |
Synta Pharmaceuticals, Corp. |
Fused heterocyclic compounds
|
JP2007511596A
(ja)
|
2003-11-17 |
2007-05-10 |
ファイザー・プロダクツ・インク |
癌の治療において有用なピロロピリミジン化合物
|
AR046845A1
(es)
|
2003-11-21 |
2005-12-28 |
Novartis Ag |
Derivados de 1h-imidazo[4,5-c]quinolina para tratamiento de enfermedades dependientes de las proteino-quinasas
|
JP2007513154A
(ja)
|
2003-12-08 |
2007-05-24 |
サイトキネティクス・インコーポレーテッド |
化合物、組成物及び方法
|
AU2004308974A1
(en)
|
2003-12-22 |
2005-07-14 |
Gilead Sciences, Inc. |
Kinase inhibitor phosphonate conjugates
|
ES2339670T3
(es)
|
2003-12-23 |
2010-05-24 |
Novartis Ag |
Inhibidores heterociclicos biciclicos de la quinasa p-38.
|
WO2005067901A2
(fr)
|
2004-01-08 |
2005-07-28 |
Michigan State University |
Methodes permettant de traiter et de prevenir l'hypertension et les troubles associes a l'hypertension
|
US20060025383A1
(en)
|
2004-02-03 |
2006-02-02 |
Neil Wishart |
Aminobenzoxazoles as therapeutic agents
|
NZ549046A
(en)
|
2004-02-13 |
2010-06-25 |
Banyu Pharma Co Ltd |
Fused-ring 4-oxopyrimidine derivative
|
US20050187418A1
(en)
|
2004-02-19 |
2005-08-25 |
Small Brooke L. |
Olefin oligomerization
|
WO2005080394A1
(fr)
|
2004-02-24 |
2005-09-01 |
Bioaxone Therapeutique Inc. |
Derives de piperidine substitues en position 4
|
CA2557575A1
(fr)
|
2004-02-27 |
2005-09-15 |
F. Hoffmann-La Roche Ag |
Derives fusionnes de pyrazole
|
MXPA06009462A
(es)
|
2004-02-27 |
2007-03-15 |
Hoffmann La Roche |
Derivados pirazolo heteroaril fusionados.
|
US20070293489A1
(en)
|
2004-04-02 |
2007-12-20 |
Jerry Adams |
Substituted Pyrazolopyrimidines
|
AP2139A
(en)
|
2004-04-02 |
2010-08-21 |
Osi Pharm Inc |
6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors.
|
AU2005238386A1
(en)
|
2004-04-30 |
2005-11-10 |
Takeda Pharmaceutical Company Limited |
Heterocyclic amide compound and use thereof as an MMP-13 inhibitor
|
DE102004022897A1
(de)
|
2004-05-10 |
2005-12-08 |
Bayer Cropscience Ag |
Azinyl-imidazoazine
|
CA2566436C
(fr)
|
2004-05-13 |
2011-05-10 |
Vanderbilt University |
Inhibiteurs selectifs de la phosphoinositide-3-kinase delta pour inhiber l'angiogenese
|
LT2612862T
(lt)
|
2004-05-13 |
2017-01-25 |
Icos Corporation |
Chinazolinonai kaip žmogaus fosfatidilinozitol-3-kinazės delta inhibitoriai
|
CA2567883A1
(fr)
|
2004-05-25 |
2005-12-15 |
Icos Corporation |
Methodes de traitement et/ou de prevention de la proliferation aberrante des cellules hematopoietiques
|
JP2008501707A
(ja)
|
2004-06-04 |
2008-01-24 |
アイコス、コーポレーション |
マスト細胞障害を処置するための方法
|
GB0420722D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
WO2006038865A1
(fr)
|
2004-10-01 |
2006-04-13 |
Betagenon Ab |
Derives de nucleotides servant a traiter le diabete de type 2 ou d'autres maladies
|
US8212011B2
(en)
|
2004-11-03 |
2012-07-03 |
University Of Kansas |
Novobiocin analogues
|
WO2006050501A2
(fr)
*
|
2004-11-03 |
2006-05-11 |
University Of Kansas |
Analogues de novobiocine en tant qu'agents anticancereux
|
US8212012B2
(en)
|
2004-11-03 |
2012-07-03 |
University Of Kansas |
Novobiocin analogues having modified sugar moieties
|
US7622451B2
(en)
|
2004-11-03 |
2009-11-24 |
University Of Kansas |
Novobiocin analogues as neuroprotective agents and in the treatment of autoimmune disorders
|
GB0425035D0
(en)
|
2004-11-12 |
2004-12-15 |
Novartis Ag |
Organic compounds
|
WO2006068760A2
(fr)
|
2004-11-19 |
2006-06-29 |
The Regents Of The University Of California |
Pyrazolopyrimidines anti-inflammatoires
|
EP1824821A2
(fr)
|
2004-11-23 |
2007-08-29 |
PTC Therapeutics, Inc. |
Derives de carbazole, de carboline et d'indole utilises dans l'inhibition de la production de vegf
|
TW200637843A
(en)
|
2005-01-10 |
2006-11-01 |
Bristol Myers Squibb Co |
Phenylglycinamide derivatives useful as anticoagulants
|
US20060156485A1
(en)
|
2005-01-14 |
2006-07-20 |
The Procter & Gamble Company |
Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof
|
PE20061119A1
(es)
*
|
2005-01-19 |
2006-11-27 |
Aventis Pharma Sa |
PIRAZOLO PIRIDINAS SUSTITUIDAS COMO INHIBIDORES DE CINASAS FAK, KDR Y Tie
|
GB0501999D0
(en)
|
2005-02-01 |
2005-03-09 |
Sentinel Oncology Ltd |
Pharmaceutical compounds
|
CA2598409A1
(fr)
|
2005-02-17 |
2006-08-24 |
Icos Corporation |
Procede d'inhibition d'accumulation de leucocytes
|
US7579348B2
(en)
|
2005-02-25 |
2009-08-25 |
Pgxhealth, Llc |
Derivatives of 8-substituted xanthines
|
US20090124654A1
(en)
|
2005-03-01 |
2009-05-14 |
Mjalli Adnan M M |
Aryl and Heteroaryl Compounds, Compositions, Methods of Use
|
RU2007140733A
(ru)
|
2005-04-06 |
2009-05-20 |
Айрм Ллк (Bm) |
Диариламинсодержащие соединения и композиции, и их применение в качестве модуляторов ядерных рецепторов стероидного гормона
|
KR100781704B1
(ko)
|
2005-04-20 |
2007-12-03 |
에스케이케미칼주식회사 |
피리딘 유도체와 이의 제조방법, 및 이를 포함하는약제조성물
|
AR055916A1
(es)
|
2005-04-22 |
2007-09-12 |
Wyeth Corp |
Derivados de dihidrobenzofurano, usos de los mismos en la preparacion de un medicamento y composicion farmaceutica
|
AU2006239677A1
(en)
|
2005-04-25 |
2006-11-02 |
Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic |
Use of compounds to enhance processivity of telomerase
|
KR20140026644A
(ko)
|
2005-06-22 |
2014-03-05 |
케모센트릭스, 인크. |
아자인다졸 화합물 및 사용방법
|
US7799795B2
(en)
*
|
2005-06-27 |
2010-09-21 |
Amgen Inc. |
Aryl nitrile compounds and compositions and their uses in treating inflammatory and related disorders
|
US20100190788A1
(en)
|
2005-07-11 |
2010-07-29 |
Olivier Defert |
Amide derivatives as kinase inhitors
|
US20100168102A9
(en)
|
2005-07-11 |
2010-07-01 |
Devgen Nv |
Amide Derivatives as Kinase Inhibitors
|
GB0516723D0
(en)
|
2005-08-15 |
2005-09-21 |
Novartis Ag |
Organic compounds
|
MX2008002590A
(es)
|
2005-08-25 |
2008-03-18 |
Hoffmann La Roche |
Inhibidores de la p38-map-cinasa y metodos para el uso de los mismos.
|
US20070049591A1
(en)
|
2005-08-25 |
2007-03-01 |
Kalypsys, Inc. |
Inhibitors of MAPK/Erk Kinase
|
BRPI0614884A2
(pt)
*
|
2005-08-25 |
2011-04-19 |
Hoffmann La Roche |
inibidores de p38 map cinase e métodos para uso dos mesmos
|
WO2007025534A1
(fr)
|
2005-09-01 |
2007-03-08 |
Bioagency Ag |
Derives de fredericamycine
|
AU2006297414A1
(en)
|
2005-09-29 |
2007-04-12 |
Wyeth |
1- (1H- indol- 1-yl) -3- (methylamino) -1- phenylpropan-2-ol derivatives and related compounds as modulators of the monoamine reuptake for the treatment of vasomotor symptoms (VMS)
|
MY148491A
(en)
*
|
2005-11-17 |
2013-04-30 |
Osi Pharm Inc |
FUSED BICYCLIC mTOR INHIBITORS
|
WO2007061763A2
(fr)
*
|
2005-11-22 |
2007-05-31 |
Merck & Co., Inc. |
Antagonistes des recepteurs de l’indole orexine
|
AR057960A1
(es)
|
2005-12-02 |
2007-12-26 |
Osi Pharm Inc |
Inhibidores de proteina quinasa biciclicos
|
WO2007075554A2
(fr)
|
2005-12-19 |
2007-07-05 |
Osi Pharmaceuticals, Inc. |
Traitement combine avec une composition d’inhibiteur de proteine kinase heterobicyclique a noyau 6,6-bicyclique et d'agents anticancereux
|
CA2635231C
(fr)
*
|
2005-12-29 |
2014-07-15 |
Abbott Laboratories |
Inhibiteurs de proteines kinases
|
EP1981890A2
(fr)
|
2006-01-25 |
2008-10-22 |
OSI Pharmaceuticals, Inc. |
INHIBITEURS DE mTOR INSATURES
|
WO2007089669A2
(fr)
|
2006-01-26 |
2007-08-09 |
Wyeth |
Procédés de préparation de composés
|
RU2008139599A
(ru)
|
2006-03-07 |
2010-04-20 |
Эррэй Биофарма Инк. (Us) |
Гетеробициклические производные пиразола и способы их применения
|
EP1996193A2
(fr)
|
2006-03-13 |
2008-12-03 |
OSI Pharmaceuticals, Inc. |
Traitement combiné avec un inhibiteur de kinase egfr et un agent sensibilisant les cellules tumorales aux effets des inhibiteurs de kinase egfr
|
US7566565B2
(en)
|
2006-03-24 |
2009-07-28 |
Syntonix Pharmaceuticals, Inc. |
PC5 as a factor IX propeptide processing enzyme
|
US20100273776A1
(en)
|
2006-03-29 |
2010-10-28 |
FOLDRx PHARMACEUTICALS, INC |
Inhibition of alpha-synuclein toxicity
|
PT2004654E
(pt)
|
2006-04-04 |
2013-08-27 |
Univ California |
Derivados de pirazolopirimidina para utilização como antagonistas da quinase
|
WO2007121453A2
(fr)
|
2006-04-17 |
2007-10-25 |
The Regents Of The University Of California |
Agents chélateurs de 2-hydroxy-1-oxo-1,2-dihydro-isoquinoline
|
ATE549337T1
(de)
|
2006-04-21 |
2012-03-15 |
Novartis Ag |
Purinderivate zur verwendung als adenosin-a2a- rezeptoragonisten
|
GB0607950D0
(en)
|
2006-04-21 |
2006-05-31 |
Novartis Ag |
Organic compounds
|
US8381806B2
(en)
|
2006-04-21 |
2013-02-26 |
Shell Oil Company |
Joint used for coupling long heaters
|
GB0607948D0
(en)
|
2006-04-21 |
2006-05-31 |
Novartis Ag |
Organic compounds
|
JP2009536161A
(ja)
|
2006-04-25 |
2009-10-08 |
アステックス、セラピューティックス、リミテッド |
医薬化合物
|
EP2037931A2
(fr)
|
2006-04-25 |
2009-03-25 |
Astex Therapeutics Limited |
Combinaisons pharmaceutiques contenant des inhibiteurs du pk et des autres agents actifs
|
DE102006020327A1
(de)
|
2006-04-27 |
2007-12-27 |
Bayer Healthcare Ag |
Heterocyclisch substituierte, anellierte Pyrazol-Derivate und ihre Verwendung
|
JP2009537621A
(ja)
|
2006-05-22 |
2009-10-29 |
アストラゼネカ アクチボラグ |
インドール誘導体
|
US20080003254A1
(en)
*
|
2006-05-23 |
2008-01-03 |
Abbott Laboratories |
Systems and methods for delivering a rapamycin analog that do not inhibit human coronary artery endothelial cell migration
|
GB0610242D0
(en)
|
2006-05-23 |
2006-07-05 |
Novartis Ag |
Organic compounds
|
GB0610317D0
(en)
|
2006-05-24 |
2006-07-05 |
Medical Res Council |
Antiparasitic compounds and compositions
|
ES2344760T3
(es)
*
|
2006-07-20 |
2010-09-06 |
Amgen Inc. |
Compuestos de piridona sustituidos y metodo de uso.
|
PT2049502E
(pt)
|
2006-07-28 |
2012-04-02 |
Novartis Ag |
Quinazolinas 2,4-substituídas como inibidores da lípido cinase
|
AU2007284562B2
(en)
*
|
2006-08-16 |
2013-05-02 |
Exelixis, Inc. |
Using PI3K and MEK modulators in treatments of cancer
|
EP2061764B1
(fr)
|
2006-08-22 |
2014-07-02 |
Technion Research & Development Foundation LTD. |
Dérivés hétérocycliques se liant au récepteur des benzodiazépines de type périphérique (pbr)
|
WO2008024977A2
(fr)
|
2006-08-24 |
2008-02-28 |
Serenex, Inc. |
Dérivés d'isoquinoline, quinazoline et phtalazine
|
JP5399905B2
(ja)
|
2006-09-01 |
2014-01-29 |
センワ バイオサイエンシズ インコーポレイテッド |
セリン−トレオニンタンパク質キナーゼおよびparp調節因子
|
WO2008025755A1
(fr)
|
2006-09-01 |
2008-03-06 |
Basf Se |
utilisation d'hÉTÉrocycles contenant de l'azote dans les cosmÉtiques dermatologiques
|
EP1903044A1
(fr)
|
2006-09-14 |
2008-03-26 |
Novartis AG |
Derivés de l'adénosine en tant qu' agonistes du récepteur A2A
|
EP1900729A1
(fr)
|
2006-09-15 |
2008-03-19 |
Novartis AG |
Benzoxazoles et oxazolopyridines et leur utilisation comme inhibiteurs de Janus kinases
|
US8492405B2
(en)
|
2006-10-18 |
2013-07-23 |
Takeda Pharmaceutical Company Limited |
Glucokinase-activating fused heterocyclic compounds and methods of treating diabetes and obesity
|
US7772180B2
(en)
|
2006-11-09 |
2010-08-10 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
JP5313909B2
(ja)
|
2006-11-13 |
2013-10-09 |
アイコス コーポレイション |
炎症性疾患および癌の処置のためのチエノピリミジノン
|
WO2008063625A2
(fr)
|
2006-11-20 |
2008-05-29 |
Adolor Corporation |
Composés pyridiniques et procédés relatifs à leur utilisation
|
EP2132178B1
(fr)
|
2006-12-20 |
2015-08-19 |
Merck Sharp & Dohme Corp. |
Inhibiteurs de jnk
|
US8283345B2
(en)
|
2006-12-22 |
2012-10-09 |
Industrial Research Limited |
Azetidine analogues of nucleosidase and phosphorylase inhibitors
|
WO2008083070A1
(fr)
|
2006-12-29 |
2008-07-10 |
Neurogen Corporation |
Ligands des récepteurs du crf1 comprenant des groupes fonctionnels hétéroaryle bicycliques
|
EA200900983A1
(ru)
|
2007-01-26 |
2010-02-26 |
Айрм Ллк |
Соединения и композиции в качестве ингибиторов киназы
|
EP2073799A4
(fr)
|
2007-03-12 |
2009-08-19 |
Vm Discovery Inc |
Nouveaux agents modulateurs des canaux d'ions calcium
|
UA98955C2
(ru)
|
2007-03-23 |
2012-07-10 |
Амген Инк. |
Гетероциклические соединения и их применение
|
ES2446417T3
(es)
|
2007-03-23 |
2014-03-07 |
Amgen Inc. |
Derivados de quinolina o quinoxalina sustituidos en 3 y su uso como inhibidores de fosfatidilinositol 3-cinasa (PI3K)
|
US7919498B2
(en)
|
2007-03-23 |
2011-04-05 |
Amgen Inc. |
Substituted pyrazolo[3,4-d]pyrimidines as PI3K inhibitors
|
WO2008156513A2
(fr)
|
2007-03-29 |
2008-12-24 |
University Of Connecticut |
Méthodes pour protéger le muscle squelettique contre une lésion
|
EP2134682B1
(fr)
|
2007-04-13 |
2011-12-14 |
Sanofi |
Synthèse de n-aminoindoles catalysée par métal de transition
|
WO2008125014A1
(fr)
|
2007-04-13 |
2008-10-23 |
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. |
Composés d'urée, leurs procédés de préparation et leurs utilisations pharmaceutiques
|
JP2010163361A
(ja)
|
2007-04-27 |
2010-07-29 |
Dainippon Sumitomo Pharma Co Ltd |
キノリン誘導体
|
US7960353B2
(en)
*
|
2007-05-10 |
2011-06-14 |
University Of Kansas |
Novobiocin analogues as neuroprotective agents and in the treatment of autoimmune disorders
|
US20090214529A9
(en)
|
2007-05-22 |
2009-08-27 |
Taigen Biotechnology Co., Ltd. |
Kinesin inhibitors
|
US9603848B2
(en)
|
2007-06-08 |
2017-03-28 |
Senomyx, Inc. |
Modulation of chemosensory receptors and ligands associated therewith
|
US7928111B2
(en)
|
2007-06-08 |
2011-04-19 |
Senomyx, Inc. |
Compounds including substituted thienopyrimidinone derivatives as ligands for modulating chemosensory receptors
|
EP2173747B1
(fr)
|
2007-06-26 |
2011-12-21 |
Sanofi |
Synthèse régiosélective catalysée par un métal de benzimidazoles et d'azabenzimidazoles condensés
|
US8685962B2
(en)
|
2007-07-02 |
2014-04-01 |
Technion Research & Development Foundation Limited |
Compositions, articles and methods comprising TSPO ligands for preventing or reducing tobacco-associated damage
|
RU2345996C1
(ru)
|
2007-07-17 |
2009-02-10 |
Андрей Александрович Иващенко |
Аннелированные азагетероциклические амиды, включающие пиримидиновый фрагмент, способ их получения и применения
|
US20090053192A1
(en)
|
2007-08-10 |
2009-02-26 |
Burnham Institute For Medical Research |
Tissue-nonspecific alkaline phosphatase (tnap) activators and uses thereof
|
CN106279283A
(zh)
|
2007-08-13 |
2017-01-04 |
症变治疗公司 |
新颖的葡糖激酶活化剂
|
EP2176259B1
(fr)
|
2007-08-14 |
2011-03-30 |
Bayer Schering Pharma Aktiengesellschaft |
Imidazoles fusionnés pour le traitement du cancer
|
JP5227965B2
(ja)
|
2007-10-03 |
2013-07-03 |
独立行政法人理化学研究所 |
ニトロトリアゾール誘導体、およびそれを用いる化合物の製造方法
|
US20110160232A1
(en)
|
2007-10-04 |
2011-06-30 |
Pingda Ren |
Certain chemical entities and therapeutic uses thereof
|
KR20100089082A
(ko)
|
2007-10-15 |
2010-08-11 |
아스트라제네카 아베 |
조합 059
|
JP2009104221A
(ja)
*
|
2007-10-19 |
2009-05-14 |
Fujitsu Ltd |
情報システム
|
US20110218210A1
(en)
|
2007-11-02 |
2011-09-08 |
Taiga Biotechnologies |
Compounds for treating abnormal cellular proliferation
|
AU2008321099A1
(en)
|
2007-11-13 |
2009-05-22 |
Icos Corporation |
Inhibitors of human phosphatidyl-inositol 3-kinase delta
|
US20090163481A1
(en)
|
2007-12-13 |
2009-06-25 |
Murphy Brian J |
Ppar-delta ligands and methods of their use
|
US7960397B2
(en)
|
2007-12-28 |
2011-06-14 |
Institute Of Experimental Botany, Academy Of Sciences Of The Czech Republic |
6,9-disubstituted purine derivatives and their use as cosmetics and cosmetic compositions
|
JP5869222B2
(ja)
*
|
2008-01-04 |
2016-02-24 |
インテリカイン, エルエルシー |
特定の化学的実体、組成物および方法
|
US8193182B2
(en)
|
2008-01-04 |
2012-06-05 |
Intellikine, Inc. |
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
|
WO2009089425A1
(fr)
|
2008-01-09 |
2009-07-16 |
Pgxhealth Llc |
Traitement intrathécal d'une douleur neuropathique avec des agonistes a2ar
|
WO2009100406A2
(fr)
|
2008-02-07 |
2009-08-13 |
Synta Pharmaceuticals Corp. |
Formulations topiques pour le traitement du psoriasis
|
CN101983062A
(zh)
|
2008-02-07 |
2011-03-02 |
吉利德帕洛阿尔托股份有限公司 |
提高abca-1的化合物及其用途
|
TWI444384B
(zh)
|
2008-02-20 |
2014-07-11 |
Gilead Sciences Inc |
核苷酸類似物及其在治療惡性腫瘤上的用途
|
US8993580B2
(en)
|
2008-03-14 |
2015-03-31 |
Intellikine Llc |
Benzothiazole kinase inhibitors and methods of use
|
US8637542B2
(en)
*
|
2008-03-14 |
2014-01-28 |
Intellikine, Inc. |
Kinase inhibitors and methods of use
|
US8404694B2
(en)
|
2008-03-20 |
2013-03-26 |
Amgen Inc. |
Aurora kinase modulators and method of use
|
US20090312406A1
(en)
|
2008-06-12 |
2009-12-17 |
Hsing-Pang Hsieh |
Coumarin compounds and their use for treating viral infection
|
MX2011000216A
(es)
*
|
2008-07-08 |
2011-03-29 |
Intellikine Inc |
Inhibidores de cinasa y metodos para su uso.
|
US20110224223A1
(en)
|
2008-07-08 |
2011-09-15 |
The Regents Of The University Of California, A California Corporation |
MTOR Modulators and Uses Thereof
|
JP2011528368A
(ja)
|
2008-07-16 |
2011-11-17 |
シェーリング コーポレイション |
二環式ヘテロ環誘導体およびgpcrモジュレーターとしてのその使用
|
US8450344B2
(en)
|
2008-07-25 |
2013-05-28 |
Aerie Pharmaceuticals, Inc. |
Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
|
CA2737219C
(fr)
|
2008-08-11 |
2017-02-28 |
Tracy Keller |
Analogues d'halofuginone pour l'inhibition d'arnt synthetases et leurs utilisations
|
EP2344481B9
(fr)
|
2008-09-23 |
2014-12-31 |
Georgetown University |
Inhibiteurs viraux et fongiques
|
CA2738429C
(fr)
|
2008-09-26 |
2016-10-25 |
Intellikine, Inc. |
Inhibiteurs heterocycliques de kinases
|
US8476282B2
(en)
|
2008-11-03 |
2013-07-02 |
Intellikine Llc |
Benzoxazole kinase inhibitors and methods of use
|
KR101787116B1
(ko)
|
2009-01-28 |
2017-10-18 |
케러 테라퓨틱스, 인코포레이티드 |
바이시클릭 피라졸로-헤테로사이클
|
US20120189641A1
(en)
|
2009-02-25 |
2012-07-26 |
OSI Pharmaceuticals, LLC |
Combination anti-cancer therapy
|
WO2010118367A2
(fr)
|
2009-04-10 |
2010-10-14 |
Progenics Pharmaceuticals, Inc. |
Pyrimidines antivirales
|
CA2760791C
(fr)
|
2009-05-07 |
2017-06-20 |
Intellikine, Inc. |
Composes heterocycliques et leurs utilisations
|
CN101602768B
(zh)
|
2009-07-17 |
2012-05-30 |
河南省农科院农副产品加工研究所 |
一种芝麻素和芝麻林素的提纯方法
|
JP6130305B2
(ja)
|
2011-02-23 |
2017-05-17 |
インテリカイン, エルエルシー |
キナーゼ阻害剤の組み合わせおよびそれらの使用
|